Literature DB >> 9072011

Developmental regulation of tissue transglutaminase during human placentation and expression in neoplastic trophoblast.

H Hager1, J Gliemann, S Hamilton-Dutoit, P Ebbesen, U Koppelhus, P H Jensen.   

Abstract

The expression of tissue transglutaminase (tTG) was studied during the formation of the normal human placenta and in molar pregnancies and choriocarcinoma, in order to correlate its expression with the functional characteristics of the recognized trophoblast cell types. tTG expression was found to be developmentally regulated. Before 6-7 weeks' gestation, only the chorionic villous cytotrophoblast expresses tTG. Thereafter the overlying syncytiotrophoblast becomes positive. tTG expression is gradually downregulated in the intermediate trophoblast cells emerging from the tips of the chorionic villi invading the uterine tissue. In the decidual wall, the intermediate trophoblast does not express tTG, whereas scattered syncytial cells, the placental bed giant cells, express tTG. Villi from complete hydatidiform mole (CHM) show tTG expression in both the cyto- and the syncytiotrophoblast. The intermediate trophoblast cells from CHM show heterogeneous tTG expression, with a majority of negative cells, whereas extravillous syncytia always express tTG. In choriocarcinoma, the tumour cells show heterogeneous tTG expression, with a majority of positive cells. Analysis of tTG protein and mRNA in placental extracts by Western and Northern blotting did not provide evidence for expression of the truncated form of tTG found in some cell types. The regulated expression of tTG in the normal placenta suggests that the enzyme is involved in important trophoblastic functions and may participate in the control of invasion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9072011     DOI: 10.1002/(SICI)1096-9896(199701)181:1<106::AID-PATH725>3.0.CO;2-K

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.

Authors:  M Cheng; P He; J Fu
Journal:  J Hum Hypertens       Date:  2016-05-12       Impact factor: 3.012

2.  Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.

Authors:  Chen Liu; Wei Wang; Nicholas Parchim; Roxanna A Irani; Sean C Blackwell; Baha Sibai; Jianping Jin; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

3.  Transglutaminase 2-dependent deamidation of glyceraldehyde-3-phosphate dehydrogenase promotes trophoblastic cell fusion.

Authors:  Kaori Iwai; Yukinao Shibukawa; Natsuko Yamazaki; Yoshinao Wada
Journal:  J Biol Chem       Date:  2013-12-27       Impact factor: 5.157

Review 4.  Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.

Authors:  Chen Liu; Rodney E Kellems; Yang Xia
Journal:  Am J Hypertens       Date:  2017-08-01       Impact factor: 2.689

5.  Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity.

Authors:  Naheed Anjum; Philip N Baker; Nicola J Robinson; John D Aplin
Journal:  Reprod Biol Endocrinol       Date:  2009-02-19       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.